Montelucaste Aurobindo (Montelukast)

Montelukast, the active ingredient in Montelucaste Aurobindo, is a leukotriene receptor antagonist presented as a tablet for oral use. It is used to treat asthma, allergic rhinitis and exercise‑induced bronchoconstriction in adults and children. GNH USA supplies Montelucaste Aurobindo as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Montelukast is a leukotriene receptor antagonist used in the management of several respiratory allergic conditions.

Asthma: provides maintenance therapy to reduce the frequency of symptoms and exacerbations. Allergic rhinitis: relieves nasal congestion, sneezing and itching associated with seasonal or perennial allergies. Exercise‑induced bronchoconstriction: prevents airway narrowing triggered by physical activity.

Montelukast is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Headache: mild to moderate pain often reported. - Abdominal pain: discomfort or cramps in the stomach area. - Cough: occasional dry or productive cough. - Nasopharyngitis: upper respiratory tract infection symptoms. - Dizziness: transient light‑headedness. - Sore throat: irritation or pain in the throat.

Serious or Rare Side Effects: - Allergic reactions: rash, angioedema, or anaphylaxis. - Neuropsychiatric events: agitation, depression, suicidal thoughts. - Hepatic enzyme elevation: abnormal liver function tests. - Stevens‑Johnson syndrome: severe skin blistering. - Eosinophilic granulomatosis with polyangiitis: rare vasculitis. - Severe bronchospasm: paradoxical worsening of breathing.

Before prescribing Montelucaste Aurobindo, clinicians should consider several safety measures.

Assess asthma control: ensure patient is on appropriate baseline therapy. Monitor neuropsychiatric symptoms: watch for mood changes or suicidal ideation. Use with caution in hepatic impairment: dose adjustment may be required. Avoid in known hypersensitivity: discontinue if allergic reaction occurs. Pregnancy and lactation: safety data are limited; weigh benefits against risks. Store at room temperature: keep in the original packaging, protect from moisture and direct sunlight.

Montelukast may interact with other medicines that affect its metabolism or therapeutic effect.

Major Interactions (Avoid): - Ketoconazole: may increase montelukast plasma levels. - Ritonavir: may raise exposure and risk of side effects. - Phenobarbital: may reduce montelukast effectiveness.

Moderate Interactions (Monitor Closely): - Fluconazole: may modestly increase drug concentration. - Erythromycin: potential for slight elevation of levels. - Warfarin: monitor INR as montelukast may affect anticoagulation. - Oral contraceptives: may slightly reduce hormonal efficacy.